• 0Shopping Cart
Kephera
  • Our Focus
    • Overview
    • Lyme Disease
    • Neurocysticercosis
    • Liver Fluke
    • Chagas Disease
    • Zika Virus
    • Pipeline
  • Technology
  • Testing Services
  • About Us
    • Overview
    • Our Team
    • Careers
    • Investors
  • News
  • Contact
  • Order Tests
  • Menu Menu

Targeting emerging and neglected diseases with new diagnostics

Driving immunoassay technology innovation

Kephera is developing immunoassays using both lab-based and point-of-care technologies to deliver diagnostics for a range of infectious diseases. Our team of innovators is working with researchers at the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC) and other institutions to help bring diagnostic results to the clinicians and patients who need them.

Explore our technology

Focused on diseases of global significance

At Kephera, we are developing lab-based and point-of-care tests to aid in the diagnosis of infectious diseases impacting millions of people globally.

Learn more about our focus

Lyme Disease

Neurocysticercosis

Liver Fluke

Chagas Disease

Zika Virus

Lab testing services available now

Our CLIA-certified clinical lab can provide accurate test results for key emerging and neglected infectious diseases.

Learn about our CLIA testing

Order Tests

News & Insights

June 6, 2023

Kephera Diagnostics launches CLIA testing for 3 parasitic diseases

Framingham, MA – June 5, 2023.  Kephera Diagnostics announced today the launch of CLIA laboratory tests for Chagas disease, neurocysticercosis, and liver fluke infection, which add to its existing CLIA tests for Lyme disease.  For Chagas disease, Kephera will offer...

Read more

April 14, 2023

Kephera Diagnostics prepares to launch CLIA testing for Chagas disease

Framingham, MA – April 14, 2023.  Kephera Diagnostics announced today, on World Chagas Day, that it will be launching testing for Chagas disease through its CLIA-certified laboratory in May 2023.  Kephera will offer two tests – an FDA-approved ELISA and...

Read more

April 13, 2023

Kephera Diagnostics awarded $3 million NIH grant for a new rapid test for Chagas disease

Framingham, MA – April 3, 2023.  The National Institute of Allergy and Infectious Diseases (NIAID), an agency of the National Institutes of Health (NIH), has awarded a Phase II, $3,050,000 Small Business Innovative Research (SBIR) grant to Kephera Diagnostics to...

Read more

April 13, 2023

National Institutes of Health awards SBIR grant for a test for hookworm infection

Framingham, MA – March 28, 2023.  The National Institute of Allergy and Infectious Diseases (NIAID), an agency of the National Institutes of Health (NIH), has awarded a Phase I, $600,000 Small Business Innovative Research (SBIR) grant to Kephera Diagnostics to...

Read more

October 20, 2021

Kephera Diagnostics receives Phase II contract from the National Cancer Institute for a test for liver fluke, an exotic parasite linked to bile duct cancer

Framingham, MA – October 20, 2021.  Kephera Diagnostics has been awarded a $1,999,961 million Phase II Small Business Innovative Research (SBIR) contract by the National Cancer Institute, an agency of the National Institutes of Health, for a test for liver...

Read more

September 23, 2021

NIAID awards Phase I contract to Kephera Diagnostics for the development of a new test for Chagas disease

National Institutes of Health awards contract to develop a test-of-cure for Chagas disease Framingham, MA – September 23, 2021.  The National Institute of Allergy and Infectious Diseases (NIAID), an agency of the National Institutes of Health (NIH), has awarded a...

Read more

1 Grant Street, Suite 300,
Framingham, MA 01702
info@kephera.com
+1 774-777-3558
  • Our Focus
  • Technology
  • Testing Services
  • About Us
  • News
  • Contact
© 2023 Kephera Diagnostics, LLC
FCOI Policy Terms & Conditions Privacy Policy
Design and Development by RainCastle Communications

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Dismiss


How we use cookies

We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.

We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.

We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.

Other external services

We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Google reCaptcha Settings:

Vimeo and Youtube video embeds:

Privacy Policy

You can read about our cookies and privacy settings in detail on our Privacy Policy Page.

Privacy Policy

Sample Shipping Instructions

  1. Before placing samples in shipping container:
    • Make sure there is no leakage or visible contamination outside the specimen container and that there are no needles or other sharps in the package that could cause injury or pathogenic exposure to anyone handling or opening the package and inner containers.
    • Make sure that all tube tops or caps are secure and tubes are labeled properly with NAME, DOB and SAMPLE COLLECTION DATE.
    • Make sure labels are securely attached to each transport tube.
    • Place the tubes with samples in biosafety bag.
    • Add completed test requisition form to outside pocket of biosafety bag.
  2. When packaging for shipping, ensure that shipping conditions maintain the required temperature:
    • Refrigerated serum or plasma samples can be shipped refrigerated (on ice pack).
    • Frozen serum or plasma samples can be shipped refrigerated (on ice pack) or on dry ice.
    • Whole blood can be shipped at ambient temperature.
  3. Ship samples via overnight delivery to arrive Monday through Thursday.
  4. Ship samples to:
    • Kephera Diagnostics
    • Attn: CLIA Laboratory
    • 1 Grant St., Suite 300
    • Framingham, MA 01702-6767

Sample Collection Instructions

  1. All testing of samples in Kephera Diagnostics’ laboratory must be ordered by an authorized provider.
  2. Use universal precautions when handling specimens containing blood or other potentially infectious material. Specimens must be handled in a safe manner and according to applicable legal requirements or guidance. Information on safe specimen handling may be obtained from the U.S. Occupational Safety and Health Administration (OSHA) and the Centers for Disease Control and Prevention (CDC).
  3. Sample handling after collection:
    1. Handling:
      • After sample collection, invert the tube 5-10 times.
      • For serum collection, allow the blood to clot for sixty minutes and separate by centrifugation (15 minutes at 2200-2500 RPM).
      • For EDTA plasma collection, separate plasma by centrifugation (15 minutes at 2200-2500 RPM).
      • Transfer the serum or plasma to a plastic tube with screw cap and make sure to close it tightly.
      • The serum and plasma samples should be clear and free from red cells.
      • If EDTA plasma is acceptable for the test, the whole blood can be sent in a tightly closed lavender top (K2 EDTA) tube.
    2. Acceptable sample volume:
      • Serum: minimum 0.5 mL, 1 mL is desirable
      • Whole blood from venipuncture: minimum 2 mL
      • Whole blood from fingerstick: minimum 0.35 mL
    3. Specimen labeling: Each sample must be labeled with the following:
      • Patient’s full name (last and first name)
      • Patient’s Date of Birth
      • Date sample was collected
    4. Specimen rejection:
        • Unlabeled tubes
        • Hemolyzed, lipemic, icteric or cloudy samples
  4. Sample storage prior to shipment:
    1. Serum and plasma:
      • Room temperature for 24 hours
      • 2 – 8°C for 96 hours, after which sample can be stored frozen for indefinite time
      • Frozen at ‑20°C or below for indefinite time
      • Serum or plasma samples should not go through freeze-thaw cycles. Samples subject to multiple freeze-thaw cycles may yield anomalous results.
    2. Whole blood (EDTA):
      • Room temperature or 2° – 8°C for 24 hours

Terms and Conditions - Privacy Policy